Peijia Medical Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Peijia Medical stock has a consensus rating of "Strong Buy" and an average price target of $9.65. The average 1-year stock price forecast is 138.86% higher than the current stock price, while the lowest is $8.54 (+111.39%) and the highest is $10.86 (+168.81%).

Price Target: $9.65 (+138.86%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$8.54	$9.65	$9.79	$10.86
Change	+111.39%	+138.86%	+142.33%	+168.81%

* Price targets were last updated on Mar 31, 2026.

Analyst Ratings

The average analyst rating for Peijia Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Aug '25	Sep '25	Nov '25	Jan '26	Mar '26	Apr '26
Strong Buy	3	3	3	3	3	3
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst CICC No rating	CICC	Buy Maintains $10.00	Buy	Maintains	$10.00	+147.52%	Mar 31, 2026
Unknown Analyst Huatai Securities No rating	Huatai Securities	Buy Maintains $10.66	Buy	Maintains	$10.66	+163.86%	Mar 31, 2026

Financial Forecast

Revenue This Year

886.84M

from 712.87M

24.40%

from 712.87M

Revenue Next Year

1.18B

from 886.84M

33.52%

from 886.84M

EPS This Year

n/a

from -0.31

EPS Next Year

0.15

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	136.53M	250.83M	441.13M	615.48M	712.87M	886.84M
Revenue Growth	253.21%	83.71%	75.86%	39.53%	15.82%	24.40%
Gross Profit	95.65M	176.20M	325.37M	433.62M	486.05M	609.92M
Gross Margin	70.06%	70.25%	73.76%	70.45%	68.18%	68.78%
Operating Income	-235.87M	-323.12M	-328.61M	-229.70M	-196.14M	3.63M
Net Income	-574.22M	-407.81M	-392.53M	-226.58M	-203.29M	8.34M
EPS	-	-	-	-	-0.31	-
Free Cash Flow	-250.08M	-73.89M	-862.08M	-124.36M	-407.32M	-55.00M
No. Analysts	-	-	-	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue	2026	2027	2028
High	909.3M
Avg	886.8M
Low	868.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	27.6%
Avg	24.4%
Low	21.8%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-